EE405 Cost-Effectiveness Analysis of Different Recombinant Factor VIII for Prophylactic Treatment of Previously Untreated Patients With Severe Hemophilia A in China
Abstract
Authors
L Yang J Peng C Gu Z Wang G Zuo
L Yang J Peng C Gu Z Wang G Zuo
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now